Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration

被引:109
作者
Evans, Jennifer W. [1 ]
Szczepanik, Joanna [1 ]
Brutsche, Nancy [1 ]
Park, Lawrence T. [1 ]
Nugent, Allison C. [1 ]
Zarate, Carlos A., Jr. [1 ]
机构
[1] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, 10 Ctr Dr,Bldg 10,Room 7-5331, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
Default mode network; Functional magnetic resonance imaging (fMRI); Glutamatergic modulator; Ketamine; Major depressive disorder; Resting state; ANTIDEPRESSANT EFFICACY; FUNCTIONAL CONNECTIVITY; NETWORK; CORTEX; REPLICATION; ANTAGONIST; SYMPTOMS; MATTER; MRI;
D O I
10.1016/j.biopsych.2018.01.027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: The symptoms of major depressive disorder (MDD) are rapidly alleviated by administration of a single dose of the glutamatergic modulator ketamine. However, few studies have investigated the potential sustained neural effects of this agent beyond immediate infusion. This study used functional magnetic resonance imaging to examine the effect of a single ketamine infusion on the resting state default mode network (DMN) at 2 and 10 days after a single ketamine infusion in unmedicated subjects with MDD as well as healthy control subjects (HCs). METHODS: Data were drawn from a double-blind, placebo-controlled crossover study of 58 participants (33 with MDD and 25 HCs) who received an intravenous infusion of either ketamine hydrochloride (0.5 mg/kg) or placebo on 2 separate test days spaced 2 weeks apart. Eight minutes of functional magnetic resonance imaging resting state data was acquired at baseline and at about 2 and 10 days after both infusions. The DMN was defined using seed-based correlation and was compared across groups and scans. RESULTS: In subjects with MDD, connectivity between the insula and the DMN was normalized compared with HCs 2 days postketamine infusion. This change was reversed after 10 days and did not appear in either of the placebo scans. Group-specific connectivity differences in drug response were observed, most notably in the insula in subjects with MDD and in the thalamus in HCs. CONCLUSIONS: Connectivity changes in the insula in subjects with MDD suggest that ketamine may normalize the interaction between the DMN and salience networks, supporting the triple network dysfunction model of MDD.
引用
收藏
页码:582 / 590
页数:9
相关论文
共 53 条
  • [11] Decoding the Role of the Insula in Human Cognition: Functional Parcellation and Large-Scale Reverse Inference
    Chang, Luke J.
    Yarkoni, Tal
    Khaw, Mel Win
    Sanfey, Alan G.
    [J]. CEREBRAL CORTEX, 2013, 23 (03) : 739 - 749
  • [12] Linear mixed-effects modeling approach to FMRI group analysis
    Chen, Gang
    Saad, Ziad S.
    Britton, Jennifer C.
    Pine, Daniel S.
    Cox, Robert W.
    [J]. NEUROIMAGE, 2013, 73 : 176 - 190
  • [13] AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages
    Cox, RW
    [J]. COMPUTERS AND BIOMEDICAL RESEARCH, 1996, 29 (03): : 162 - 173
  • [14] Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers
    De Simoni, S.
    Schwarz, A. J.
    O'Daly, O. G.
    Marquand, A. F.
    Brittain, C.
    Gonzales, C.
    Stephenson, S.
    Williams, S. C. R.
    Mehta, M. A.
    [J]. NEUROIMAGE, 2013, 64 : 75 - 90
  • [15] Glutamate and the neural basis of the subjective effects of ketamine
    Deakin, J. F. William
    Lees, Jane
    Mckie, Shane
    Hallak, Jaime E. C.
    Williams, Steve R.
    Dursun, Serdar M.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (02) : 154 - 164
  • [16] Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans: A Validation Using Antipsychotic and Glutamatergic Agents
    Doyle, O. M.
    De Simoni, S.
    Schwarz, A. J.
    Brittain, C.
    O'Daly, O. G.
    Williams, S. C. R.
    Mehta, M. A.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (01) : 151 - 160
  • [17] Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
    Driesen, N. R.
    McCarthy, G.
    Bhagwagar, Z.
    Bloch, M.
    Calhoun, V.
    D'Souza, D. C.
    Gueorguieva, R.
    He, G.
    Ramachandran, R.
    Suckow, R. F.
    Anticevic, A.
    Morgan, P. T.
    Krystal, J. H.
    [J]. MOLECULAR PSYCHIATRY, 2013, 18 (11) : 1199 - 1204
  • [18] Resting-state connectivity biomarkers define neurophysiological subtypes of depression
    Drysdale, Andrew T.
    Grosenick, Logan
    Downar, Jonathan
    Dunlop, Katharine
    Mansouri, Farrokh
    Meng, Yue
    Fetcho, Robert N.
    Zebley, Benjamin
    Oathes, Desmond J.
    Etkin, Amit
    Schatzberg, Alan F.
    Sudheimer, Keith
    Keller, Jennifer
    Mayberg, Helen S.
    Gunning, Faith M.
    Alexopoulos, George S.
    Fox, Michael D.
    Pascual-Leone, Alvaro
    Voss, Henning U.
    Casey, B. J.
    Dubin, Marc J.
    Liston, Conor
    [J]. NATURE MEDICINE, 2017, 23 (01) : 28 - 38
  • [19] First S. R. G. M., 2002, STRUCTURED CLIN INTE
  • [20] Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder
    Furey, Maura L.
    Drevets, Wayne C.
    Hoffman, Elana M.
    Frankel, Erica
    Speer, Andrew M.
    Zarate, Carlos A., Jr.
    [J]. JAMA PSYCHIATRY, 2013, 70 (03) : 280 - 290